A Study Assessing Association Between Body Weight Changes and Diabetic Parameters in Drug Naive Subjects With Type-2 Diabetes Mellitus And Treated With Ipragliozin.
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Nov 2016 New trial record
- 31 Oct 2016 Results published in the Drugs in R and D